Inhibikase Therapeutics, Inc.

DB:IQT0 Stock Report

Market Cap: €7.0m

Inhibikase Therapeutics, Inc. Company Information

Inhibikase Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Inhibikase Therapeutics, Inc.
  • Ticker: IQT0
  • Exchange: DB
  • Founded: 2008
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$7.381m
  • Listing Market Cap: US$6.984m
  • Shares Outstanding: 5.35m
  • Website: https://www.inhibikase.com

Number of Employees

Location

  • Inhibikase Therapeutics, Inc.
  • 3350 Riverwood Parkway SE
  • Suite 1900
  • Atlanta
  • Georgia
  • 30339
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IKTNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDDec 2020
IQT0DB (Deutsche Boerse AG)YesCommon StockDEEURDec 2020

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/09/27 14:23
End of Day Share Price 2023/06/30 00:00
Earnings2023/06/30
Annual Earnings2022/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.